SEC Form 4 · accession 0001140361-18-027711
Nemaura Medical Inc. · NMRD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bashir Timol
Officer — Chief Business Officer · Director
Period of report
Jun 5, 2018
Accepted (ET)
Jun 7, 2018 · 5:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001602078
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 5, 2018 | J | 27,082,000 | $0.00 | A | 27,082,100 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A Convertible Preferred StockF2,F3 | $0.00 | Jun 5, 2018 | C | 27,082 | D | — | — | Common Stock, par value $0.01 | 27,082,000 | 0 | D |
Explanation of responses
- F1The Reporting Person converted all of his shares of Series A Convertible Preferred Stock into Common Stock, whereby each share of Series A Convertible Preferred was converted into 1,000 shares of Common Stock.
- F2The Reporting Person can automatically convert after all of the following events occur:(a) the sugarBEAT(R) device to be commercialized has CE regulatory approval; (b) retail sales have commenced; and (c) retail sales exceed USD$5 million, which includes any advanced sales (the "Triggering Events"); the disinterested members of the Board shall confirm the satisfaction of all Triggering Events by written notice to the Corporation's transfer agent. The Reporting Person can voluntarily convert any shares of Series A Preferred then outstanding into fully paid and nonassessable shares of Common Stock.
- F3The conversion rights do not expire.